Evidence for aggregation-independent, PrP <sup>C</sup> -mediated Aβ cellular internalization

Alejandro R. Foley, Graham Roseman, Ka Chan, Amanda Smart, Thomas S. Finn, Kevin Yang, R. Scott Lokey, Glenn L. Millhauser, Jevgenij A. Raskatov

Proceedings of the National Academy of Sciences · 2020 · 37 citations · 47 references

DOIFull text

Open access

Concepts

Abstract

Significance Amyloid β (Aβ) aggregation has been the therapeutic target of several Alzheimer’s disease (AD) clinical trials. Aβ exists in many different aggregated forms, making it exceedingly challenging to target. Evidence links intracellular Aβ accumulation and AD pathogenesis. We report that amino acids 1 to 30 of Aβ, Aβ (1–30), do not aggregate yet display cellular uptake stereospecificity when compared to its mirror image, suggesting that Aβ uptake is predominantly receptor-mediated and may be independent from its aggregation state. Additionally, we found Aβ (1–30) internalization to depend on PrP C expression. Aβ (1–30) thus represents a powerful tool to study mechanisms of Aβ cellular internalization and suggests that Aβ uptake could be modulated by therapeutically targeting high-affinity Aβ receptors.

References

47